Abstract
The Care Committee of the Mukoviszidose e.V., headed by Cornelia Meyer, has drawn up a completely revised version of the German Guidelines to Care in Cystic Fibrosis. It addresses all nursing staff concerning children, adolescents or adults with cystic fibrosis (CF) either in an inpatient and outpatient setting or in rehab clinics. The guidelines evolve along with the increased life expectancy of cystic fibrosis patients and improved quality of life which is described by CF patients and can be observed by the therapeutic CF team. For example, the treatment of secondary diseases like CFDR (CF related diabetes) which comes along with an increased life expectancy has been added over the years. It is essential that within such a complex disease pattern, professional experience of care staff who worked in specialized CF care centers (50+ patients per year) for many years has to be transferred to other nursing stuff or beginners. This is especially important in the context of the heterogeneous characteristics of this disease. Often it can be seen that the quality of the care for CF patients depends on the know-how and professional experience of the interdisciplinary CF therapists team. Moreover, it depends on the knowledge which the patient has gathered by himself by experience or learning. And, of course, it depends also on the knowledge of the relatives especially parents or partner respectively.
Highlights
Cystic fibrosis (CF) is one of the most common life-shortening inherited diseases
The guidelines evolve along with the increased life expectancy of cystic fibrosis patients and improved quality of life which is described by CF patients and can be observed by the therapeutic CF team
Often it can be seen that the quality of the care for CF patients depends on the know-how and professional experience of the interdisciplinary CF therapists team
Summary
Cystic fibrosis (CF) is one of the most common life-shortening inherited diseases. In Germany about 8000 people are affected [1]. Cystic fibrosis is caused by the mutation of a gene called cystic fibrosis transmembrane conductance regulator (CFTR) This gene defect results in the production of thick mucus in the internal organs causing inflammation, frequent lung infections and digestive problems. Despite all the positive developments we still see difficult ethiopathology in which the CF patient still dies, in some cases as a child, or its survival depends on the last line of treatment, the lung transplantation. This holds for patients in the early teenage years. The guidelines show in a practical manner which benefit might arise by using it for the caring of cystic fibrosis patients and which advantages come along for the other departments
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.